Asthma Inhaler Technique: The Complete Guide to MDI, DPI, and Spacer Use
Correct inhaler technique is one of the most important -- and most overlooked -- factors in asthma control. Studies consistently show that 50 to 90 percent of patients make at least one critical error when using their inhaler, directly reducing the amount of medication that reaches the airways. A patient using the wrong technique may appear to have poorly controlled or treatment-refractory asthma when the real problem is device misuse.
This guide covers step-by-step technique for metered-dose inhalers (MDI), dry-powder inhalers (DPI), and soft-mist inhalers (SMI), along with a device comparison, inspiratory flow requirements by device, and the eight most common errors. If you are a patient in Plantation, FL or the wider Broward County area, our team at Advanced Asthma Clinic can assess and correct your technique at any visit.
Types of Inhalers: MDI, DPI, and SMI Compared
Three main inhaler categories are used in asthma management. Understanding the mechanics of each device is essential because correct technique differs substantially between them.
| Feature | MDI (Pressurized) | DPI (Dry-Powder) | SMI (Soft-Mist) |
|---|---|---|---|
| Drive mechanism | Propellant (HFA) | Patient's inspiratory flow | Mechanical spring (Respimat) |
| Inhalation speed | Slow and steady (~30 L/min) | Fast and forceful (30-90 L/min by device) | Slow and steady |
| Spacer compatible? | Yes -- strongly recommended | No | No |
| Coordination required? | Yes (eliminated by spacer) | No (breath-actuated) | Press-and-breathe |
| Estimated lung deposition | ~20% without spacer; ~40% with spacer | ~20-30% (technique-dependent) | ~50-52% |
| Usable during exacerbation? | Yes (with spacer) | Limited (flow-dependent) | Yes |
| Common examples | ProAir HFA, Ventolin, Flovent, Symbicort MDI, Alvesco | Advair Diskus, Pulmicort Flexhaler, Breo Ellipta, Spiriva HandiHaler | Spiriva Respimat, Stiolto Respimat |
How to Use a Metered-Dose Inhaler (MDI) With a Spacer
Using a spacer (valved holding chamber) eliminates the need for perfect hand-breath coordination, reduces oropharyngeal drug deposition from approximately 80% to 20%, and is especially important for inhaled corticosteroids (ICS) and for children. Always use a spacer when one is available.
- Remove caps and inspect. Remove the cap from the MDI mouthpiece and from the spacer mouthpiece. Check both for debris or blockage.
- Shake the MDI vigorously. Shake for 5 seconds to mix the propellant and medication. If the inhaler is new or has not been used for more than 2 weeks, prime it by actuating 4 puffs into the air away from your face.
- Attach MDI to spacer. Insert the MDI canister firmly into the spacer's MDI port until it seats securely.
- Exhale fully. Breathe out completely, away from the spacer mouthpiece.
- Seal lips around the spacer mouthpiece. Form an airtight seal with your lips around the mouthpiece. Do not bite or block the opening with your tongue.
- Actuate one puff. Press the MDI canister down once to release a single dose into the spacer chamber.
- Inhale slowly and deeply. Breathe in slowly over 3-5 seconds. If you hear a whistle from the spacer's flow indicator, slow down -- you are inhaling too fast.
- Hold breath for 10 seconds. Remove the spacer from your mouth and hold your breath for 10 full seconds (or as long as comfortable) to allow complete pulmonary deposition.
- Wait before the next puff. If a second puff is prescribed, wait 30-60 seconds, shake the MDI again, and repeat from step 4.
- Rinse mouth after ICS. If using an inhaled corticosteroid, rinse your mouth with water immediately after the final dose and spit -- do not swallow.
How to Use an MDI Without a Spacer
If no spacer is available, the open-mouth technique delivers more drug to the lungs than the closed-mouth technique:
- Shake vigorously for 5 seconds. Prime if needed.
- Exhale fully.
- Hold the inhaler 1-2 inches (2-3 cm) in front of your open mouth -- do not seal your lips around the mouthpiece.
- Begin inhaling slowly, then press the canister down at the very start of your breath.
- Continue inhaling slowly over 3-5 seconds while maintaining steady flow.
- Hold breath for 10 seconds. Rinse mouth if ICS was used.
How to Use a Dry-Powder Inhaler (DPI)
DPIs are actuated entirely by the patient's breath. Medication must be drawn off a carrier lattice by turbulent inspiratory airflow -- there is no propellant. The key difference from MDI technique is that inhalation must be fast and forceful from the very start. Never exhale into a DPI; moisture from breath degrades the powder dose.
- Load the dose. Follow the device-specific loading step: twist the base (Turbuhaler), slide the lever (Diskus), open the cover (Ellipta), or pierce the capsule (HandiHaler). A click or dose-counter change confirms loading.
- Exhale away from the device. Breathe out fully, but turn your head away from the mouthpiece. Never exhale into a DPI.
- Seal lips tightly around the mouthpiece. Form a complete seal with your lips -- no gaps.
- Inhale fast and hard. Breathe in as forcefully and deeply as possible from the first moment of the breath. Inspiratory force is what aerosolizes the powder.
- Hold breath for 10 seconds.
- Rinse after ICS. If using a corticosteroid DPI (e.g., Pulmicort Flexhaler, Arnuity Ellipta), rinse your mouth with water and spit.
Peak Inspiratory Flow Requirements by DPI Device
DPI drug delivery depends entirely on the patient's ability to generate adequate inspiratory flow. During acute asthma exacerbations, many patients cannot reach these thresholds, making MDI plus spacer the preferred rescue approach. Spirometry and inspiratory flow testing can determine the most appropriate device for each patient.
| Device | Min. Peak Inspiratory Flow | Resistance | Notes |
|---|---|---|---|
| Spiriva HandiHaler | ~30 L/min | Low | Capsule-based; suitable for patients with lower flow capacity |
| Advair Diskus / Wixela Inhub | 30-60 L/min | Medium | Blister-strip; most asthma patients can achieve required flow |
| Breo Ellipta / Arnuity Ellipta | 30-90 L/min | Low-medium | Click-strip loading; once-daily convenience |
| Pulmicort Flexhaler / Symbicort Turbuhaler | >60 L/min | High | Higher resistance increases turbulence but requires strong effort |
| ProAir Digihaler (DPI) | ~60 L/min | Medium | Bluetooth sensor records flow and adherence data via companion app |
How to Use a Soft-Mist Inhaler (Respimat)
The Respimat generates a slow-moving aerosol cloud via a mechanical spring -- no propellant, no required inspiratory force. Estimated lung deposition is approximately 50-52%, the highest of any portable device. The spray lasts approximately 1.5 seconds, considerably longer than an MDI actuation, allowing easier coordination.
- Rotate the clear base half a turn in the direction of the arrows until it clicks (one dose loaded).
- Flip open the safety cap.
- Exhale fully, away from the device.
- Seal your lips around the mouthpiece.
- Begin inhaling slowly, then press the dose-release button at the start of the breath. Continue inhaling slowly and deeply over 3-5 seconds.
- Hold breath for 10 seconds.
The 8 Most Common Inhaler Errors -- and How to Fix Them
| Error | Device(s) | Consequence | Correction |
|---|---|---|---|
| Inhaling too fast | MDI | Impaction in oropharynx; <10% lung deposition | Aim for 30 L/min -- 3-5 seconds for a complete inhalation |
| Inhaling too slowly | DPI | Insufficient turbulence; powder clumps and is not aerosolized | Inhale as fast and as hard as possible from the first moment |
| Exhaling into the DPI | DPI | Moisture clumps the powder; full dose lost | Always turn head away before exhaling; never breathe out into the device |
| Not shaking the MDI | MDI | Propellant and drug separate; uneven or propellant-only dose | Shake vigorously for 5 seconds before every actuation |
| Not exhaling before inhaling | All | Reduced inhalation volume; less drug delivered per breath | Always exhale to functional residual capacity (away from device) before each puff |
| No breath-hold | All | Particles exhaled before deposition; estimated 40-50% dose loss | Hold breath for a full 10 seconds after every puff |
| Not rinsing mouth after ICS | MDI/DPI ICS | Oropharyngeal candidiasis; dysphonia (hoarseness) | Rinse with water and spit after every ICS dose; use a spacer with MDI |
| Using an empty inhaler | MDI | Propellant only delivered; no drug; patient unprotected | Track dose counter daily; never rely on the float-test (inaccurate) |
Inhaler Use in Special Populations
Children Under Age 6
Children under 4 require an MDI with a spacer fitted with an age-appropriate face mask (infant or toddler size). From ages 4 to 6, transition to a spacer with mouthpiece as soon as the child can form a reliable lip seal. DPIs are generally appropriate from age 6-7, provided the child can generate adequate inspiratory flow. Observe technique at every clinical visit -- habit errors form quickly and are difficult to correct later.
Older Adults
Arthritis or reduced hand strength can make depressing an MDI canister difficult. Breath-actuated MDIs (e.g., ProAir RespiClick) or easy-load DPIs (Ellipta platform) reduce this barrier. Cognitive decline may impair multi-step sequences -- spacers simplify MDI use to a single inhalation step. Technique should be formally assessed at every appointment.
During Acute Exacerbations
When airways are severely obstructed, follow your asthma action plan rescue protocol using an MDI with spacer. DPIs are unreliable during exacerbations due to reduced inspiratory flow. If multiple albuterol puffs fail to restore symptoms within 20 minutes, escalate per your action plan. For more on when oral corticosteroids are indicated in acute exacerbations, see our OCS dosing guide.
After Each Inhaler Use: ICS Rinse Protocol
Inhaled corticosteroids deposited in the oropharynx -- regardless of device -- carry risk of local adverse effects:
- Oropharyngeal candidiasis (thrush): white patches on tongue or palate; treat with antifungal rinse (clotrimazole troches or nystatin)
- Dysphonia (hoarseness): occurs in 5-50% of ICS users; often resolves with spacer use and rinsing
Protocol after every ICS dose: Rinse mouth with a full mouthful of water, gargle for 10 seconds, then spit. Do not swallow. A spacer with MDI reduces oropharyngeal deposition from ~80% to ~20%, substantially cutting candidiasis risk. Always consult your physician if you notice white patches in the mouth or persistent hoarseness that does not resolve.
Expert Inhaler Assessment at Advanced Asthma Clinic -- Plantation, FL
Before initiating advanced therapies such as biologics, clinical guidelines require confirming that inhaler technique and medication adherence are optimized. Uncontrolled asthma caused by poor technique can mimic treatment-refractory disease. A single technique correction visit can restore control without any change in prescription.
Schedule a technique review: Call (954) 522-7226 or visit our contact page. We serve patients in Plantation, Fort Lauderdale, Davie, Weston, and throughout Broward County and South Florida.
Lung Research Florida is currently enrolling patients for biologic and investigational asthma studies. Qualified participants may receive study medication at no cost and contribute to advancing pulmonary care. Call 954-520-7296 x1 or visit lungresearchflorida.com.
Frequently Asked Questions
How do I know if I am using my inhaler correctly?
Signs of correct technique include tasting the medication (MDI), feeling the powder (DPI), and experiencing symptom relief within 5-15 minutes of a rescue inhaler dose. The most reliable method is a hands-on technique review with your pulmonologist or respiratory therapist. At Advanced Asthma Clinic in Plantation, FL, we assess inhaler technique at every visit. Always consult your physician if your inhaler does not appear to be controlling your symptoms.
Should I use a spacer with my MDI?
Yes. A spacer (valved holding chamber) is strongly recommended for all MDI users. Spacers reduce oropharyngeal deposition from roughly 80% to 20%, increase lung deposition from approximately 20% to 40%, and eliminate the need to perfectly coordinate actuation with inhalation. They are especially critical for inhaled corticosteroids and for children under age 6.
Can I use a DPI if I have a slow breathing rate?
DPIs require a forceful deep inhalation to de-aggregate and deliver drug particles. During acute exacerbations, patients often cannot generate sufficient inspiratory flow to activate these devices effectively. In that case, an MDI with spacer or a nebulizer is preferred. Your pulmonologist can measure your peak inspiratory flow to determine the most appropriate device for your capacity.
Why do I need to rinse my mouth after using an ICS inhaler?
Inhaled corticosteroids deposited in the mouth and throat can cause oropharyngeal candidiasis (thrush) and dysphonia. Rinsing with water and spitting immediately after each ICS dose removes residual drug and substantially reduces this risk. Using a spacer with your MDI also greatly reduces oropharyngeal deposition. Always consult your physician if you notice white patches in the mouth or persistent hoarseness.
How often should I clean my inhaler and spacer?
Spacers should be washed with warm soapy water weekly, rinsed thoroughly, and air-dried -- do not rub dry, as static charge on the chamber wall reduces drug delivery. MDI mouthpieces should be wiped clean weekly. Do not immerse DPI devices in water. Replace spacers every 6-12 months or per manufacturer instructions.
My child refuses to use an inhaler. What are the alternatives?
Children under age 4 typically require an MDI with a spacer fitted with a face mask. Ages 4-6 can usually transition to a spacer with mouthpiece once a reliable lip seal is established. DPIs are generally appropriate from age 6-7 if the child can generate sufficient inspiratory flow. Nebulizers are appropriate for acute episodes but are not preferred for daily long-term therapy. Consult your physician to determine the most appropriate delivery system for your child's age and developmental stage.
Does inhaler technique affect biologic therapy eligibility?
Yes. Before initiating biologic therapy for severe asthma, clinical guidelines require confirming optimal adherence and correct inhaler technique. Uncontrolled asthma due to poor technique can mimic treatment-refractory disease. At Advanced Asthma Clinic, we conduct a comprehensive technique and adherence evaluation before any biologic assessment.
This content is provided for educational purposes only and does not constitute medical advice. Always consult your physician before making any changes to your asthma management plan. Dr. Frank Hull and the Advanced Asthma Clinic team serve patients in Plantation, FL 33324 and throughout Broward County and South Florida. Phone: (954) 522-7226.